multilayer tablet exclusion criteria from PK analysis due to emesis [Regulatives / Guidelines]

posted by jag009  – NJ, 2016-01-30 00:02 (3805 d 09:17 ago) – Posting: # 15899
Views: 4,948

Hi Shuanghe,

But does it matter if it's IR/XR with a single API or IR with API A and XR with API B?
The emesis criteria should be based on the IR Tmax. Okay, unless there is an IR product out there which has a really long Tmax such that it's actually longer than the dosing interval of the modified release.

Thanks
John

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
282 visitors (0 registered, 282 guests [including 16 identified bots]).
Forum time: 10:19 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5